Skip to main content

Year: 2023

FTI Consulting Reports Record Third Quarter 2023 Financial Results

Third Quarter 2023 Revenues of $893.3 Million, Up 15% Compared to $775.9 Million in Prior Year Quarter Third Quarter 2023 EPS of $2.34, Up 9% Compared to $2.15 in Prior Year Quarter Company Raises Lower End of Revenue and EPS Guidance Ranges for Full Year 2023WASHINGTON, Oct. 26, 2023 (GLOBE NEWSWIRE) — FTI Consulting, Inc. (NYSE: FCN) today released financial results for the third quarter ended September 30, 2023. Third quarter 2023 revenues of $893.3 million increased $117.4 million, or 15.1%, compared to revenues of $775.9 million in the prior year quarter. Excluding the estimated positive impact from foreign currency translation (“FX”), revenues increased $105.4 million, or 13.6%, compared to the prior year quarter. The increase in revenues was primarily due to higher demand in the Corporate Finance & Restructuring,...

Continue reading

Oma Savings Bank Plc’s Financial reporting and AGM in 2024

OMA SAVINGS BANK PLC, STOCK EXCHANGE RELEASE 26 OCTOBER 2023 AT 15.00 P.M. EET, FINANCIAL CALENDAROma Savings Bank Plc’s Financial reporting and AGM in 2024 Oma Savings Bank Plc (OmaSp) will publish financial information in 2024 as follows:5 February 2024 Financial Statements Release for 2023 29 April 2024 Interim Report January-March 2024 29 July 2024 Interim Report January-June 2024 28 October 2024 Interim Report January-September 2024The 2023 Financial Statements, Report of the Board of Directors and Auditor’s Report will be published in week 10. The Annual General Meeting is planned to be held on Tuesday 26 March in 2024. The Board of Directors will convene the Annual General Meeting separately.Oma Savings Bank PlcAdditional information:Minna Sillanpää, CCO, tel. +358 50 66592, minna.sillanpaa@omasp.fi DISTRIBUTIONNasdaq...

Continue reading

EDAP TMS SA to Announce Third Quarter 2023 Financial Results on November 9, 2023

Company to host conference call and webcast on Thursday, November 9th at 8:30am EDT LYON, France, October 26, 2023 — EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that it will release its financial results for the third quarter ended September 30th, 2023, before the markets open on Thursday, November 9th, 2023. An accompanying conference call and webcast will be conducted by Ryan Rhodes, Chief Executive Officer, François Dietsch, Chief Financial Officer and Ken Mobeck, Chief Financial Officer of the U.S. subsidiary. The call will be held at 8:30am EDT on Thursday, November 9th, 2023. Please refer to the information below for conference call dial-in information and webcast registration. Call Details:Date: Thursday, November 9thTime: 8:30am EDTDomestic:...

Continue reading

Lisata Therapeutics to Host Third Quarter 2023 Financial Results Conference Call on Thursday, November 2nd at 4:30 p.m. Eastern Time

BASKING RIDGE, N.J., Oct. 26, 2023 (GLOBE NEWSWIRE) — Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other serious diseases, today announced that the Company will report its financial results for third quarter ended September 30, 2023, on Thursday, November 2, 2023, after the close of trading and will host a conference call at 4:30 p.m. Eastern time. Those wishing to participate must register for the conference call by way of the following link: CLICK HERE TO REGISTER. Registered participants will receive an email containing conference call details with dial-in options. To avoid delays, we encourage participants to dial into the conference call fifteen minutes ahead of the scheduled start...

Continue reading

COMPASS Pathways announces CFO transition

LONDON, Oct. 26, 2023 (GLOBE NEWSWIRE) — COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS” or the “company”), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced that Mike Falvey, Chief Financial Officer, will depart the company on November 3, 2023, to pursue other opportunities. Mary-Rose Hughes, current Vice President of Finance at COMPASS, will assume the role of interim CFO effective today. COMPASS has begun a search to select a permanent Chief Financial Officer. “On behalf of the Board and the company, we thank Mike for his leadership and the many contributions he made during his tenure at COMPASS,” said Kabir Nath, Chief Executive Officer of COMPASS Pathways. “He played a vital role in our recently completed private placement, which both extended the...

Continue reading

Asure Software Sets November 2023 Financial Conference Schedule

AUSTIN, Texas, Oct. 26, 2023 (GLOBE NEWSWIRE) — Asure Software, Inc. (Nasdaq: ASUR), an established provider of cloud-based Human Capital Management (“HCM”) software solutions, is scheduled to participate at the following financial conferences in November: ROTH MKM 12th Annual New York Technology ConferenceDate: Wednesday, November 15, 2023Format: In-Person 1×1 and Small Group MeetingsLocation: New York, NY Craig-Hallum 14th Annual Alpha Select ConferenceDate: Thursday, November 16, 2023Format: In-Person 1×1 and Small Group MeetingsLocation: New York, NY Needham 13th Annual Virtual SaaS 1×1 ConferenceDate: Thursday, November 16, 2023Format: Virtual 1×1 and Small Group Meetings For additional information, please contact your financial institution’s representative or Patrick McKillop – Vice President Investor...

Continue reading

Teknova to Report Third Quarter 2023 Financial Results on November 9, 2023

HOLLISTER, Calif., Oct. 26, 2023 (GLOBE NEWSWIRE) — Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, today announced that the Company will report its financial results for the third quarter ended September 30, 2023, on Thursday, November 9, 2023, following the close of market. Teknova will host a webcast and conference call on Thursday, November 9, 2023, beginning at 5:30 p.m. Eastern Time. Participants can access the live webcast on the Investor Relations section of the Teknova website and at this link: https://edge.media-server.com/mmc/p/nsccw7hr. To receive a PIN number for dial in, participants can register for the webcast via this link: https://register.vevent.com/register/BI43a2f4610cbe41f5b78f7d61007caf37....

Continue reading

Absci to Participate in Upcoming Investor Conferences

VANCOUVER, Wash. and NEW YORK, Oct. 26, 2023 (GLOBE NEWSWIRE) — Absci Corporation (Nasdaq: ABSI), a generative AI drug creation company, today announced the company will be participating in the following upcoming investor conferences in New York, NY.Truist Securities 2023 BioPharma SymposiumHosting 1×1 meetings on Wednesday, November 8thStifel 2023 Healthcare ConferenceParticipating in a fireside chat on Wednesday, November 15th at 9:45 a.m. Eastern Time and hosting 1×1 meetingsCanaccord Genuity MedTech, Diagnostics and Digital Health & Services ForumParticipating in a fireside chat on Thursday, November 16th at 9:00 a.m. Eastern Time and hosting 1×1 meetingsInterested parties may access live and archived webcasts of the fireside chats on the company’s investor relations website at: investors.absci.com. About...

Continue reading

illumin Announces Date for Third Quarter 2023 Financial Results Video Conference Call

TORONTO and NEW YORK, Oct. 26, 2023 (GLOBE NEWSWIRE) — illumin (TSX: ILLM, OTC: ILLMF) (“illumin” or “Company”), a Journey Advertising technology company that empowers marketers to make smarter decisions about communicating with online consumers, is pleased to announce that it will report its third quarter 2023 financial results before market open on Thursday, November 9th, 2023. The Company will host a live video webcast to discuss the results on Thursday, November 9th, 2023, at 8:30 am Eastern Time. The webcast will be hosted by Tal Hayek, Co-Founder and Chief Executive Officer, Elliot Muchnik, Chief Financial Officer, and Nadeem Ahmed, Chief Revenue Officer, with a question-and-answer session to follow. Conference Call Details:To register for the conference call webcast and presentation, please visit: https://illumin.com/investor-information/earnings-call/ Please...

Continue reading

Pacira to Report Third Quarter 2023 Financial Results on Thursday November 2, 2023

TAMPA, Fla., Oct. 26, 2023 (GLOBE NEWSWIRE) — Pacira BioSciences, Inc. (NASDAQ:PCRX) today announced that it will report its third quarter financial results before the open of the U.S. markets on Thursday November 2, 2023. Following the release, the company will host a live conference call and webcast at 8:30 a.m. ET. For listeners who wish to participate in the question and answer session via telephone, please pre-register here. All registrants will receive dial-in information and a PIN allowing them to access the live call. In addition, a live audio of the conference call will be available as a webcast. Interested parties can access the event through the “Events” page on the Pacira website at investor.pacira.com. For those unable to participate in the live call, a replay of the webcast will be available on the Pacira website...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.